AXQ Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
44,364
-3,876
-8% -$339K 0.44% 31
2026
Q1
$4.11M Buy
+48,240
New +$4.3M 0.53% 15
2025
Q1
Sell
-21,087
Closed -$1.92M 512
2024
Q4
$1.92M Buy
+21,087
New +$2.01M 0.86% 5
2023
Q4
Sell
-5,900
Closed -$420K 664
2023
Q3
$420K Buy
+5,900
New +$441K 0.15% 235
2023
Q2
Sell
-6,017
Closed -$452K 336
2023
Q1
$452K Buy
+6,017
New +$447K 0.18% 197

Other funds holding CL

AXQ Capital's CL Position: Q2 2026 in Review

AXQ Capital reduced its Colgate-Palmolive (CL) stake by 8% in Q2 2026, selling an estimated $339K and leaving 44,364 shares worth $4.07M. The position accounts for 0.44% of the portfolio, ranked #31.

AXQ Capital first reported a position in CL in Q1 2023 and has held it in 5 quarters since. The position peaked at $4.11M in Q1 2026. 2,015 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • AXQ Capital held 44,364 shares of Colgate-Palmolive worth $4.07M as of Q2 2026.
  • AXQ Capital sold 3,876 Colgate-Palmolive shares in Q2 2026, an estimated $339K.
  • Colgate-Palmolive made up 0.44% of AXQ Capital's portfolio in Q2 2026, its #31 holding.
  • AXQ Capital first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 5 quarters since.
  • AXQ Capital's Colgate-Palmolive position peaked at $4.11M in Q1 2026.
  • 2,015 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.